Drug that ‘melts away’ tumours could replace surgery for bowel cancer, say doctors
All patients in pembrolizumab trial were found to be cancer-free after combination of drug and surgery
A “gamechanger” immunotherapy drug that “melts away” tumours dramatically increases the chances of curing bowel cancer and may even replace the need for surgery, doctors have said.
Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells.